Literature DB >> 21352299

Questionnaire survey of the efficacy of emollients for adult patients with atopic dermatitis.

Tamihiro Kawakami1, Yoshinao Soma.   

Abstract

Emollients are useful and important treatment adjuncts for patients with atopic dermatitis (AD). Heparinoid mucopolysaccharide creams or lotions are emulsion ointments for moisturizing the skin. The objective of this study was to investigate the view among adult AD patients regarding the effectiveness of emollients. We developed a questionnaire at our University Hospital to characterize how patients with AD viewed the efficacy of emollients. Patients were asked to participate prior to treatment and the questionnaire was given within 1 month of treatment. The severity of AD was graded as mild, moderate, severe or very severe. The severity scoring was performed only when the participants answered the questionnaire. Of the 110 enrolled AD patients, 103 returned the completed questionnaires. Ninety-eight patients (95.1%) used heparinoid mucopolysaccharide creams or lotions. There was a strong correlation between their view of the efficacy of the emollient and the condition of dry skin, pruritus and eczematous skin. There was a significant correlation between AD severity and the perceived efficacy of the emollient for dry skin, pruritus and eczematous skin. There was a greater sense of efficacy among patients with milder AD than in more severe AD cases. Patients who felt sufficient efficacy of the emollient for pruritus were significantly older than those who felt there was no efficacy. In addition, the age of onset of AD was significantly higher among those who felt sufficient efficacy for pruritus compared to those who felt little efficacy. We speculate that the efficacy of emollients could be demonstrated in the treatment of milder AD, but may only have partial efficacy in more severe cases. Emollient therapy might have lower efficacy for pruritus among younger or earlier onset AD patients.
© 2010 Japanese Dermatological Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21352299     DOI: 10.1111/j.1346-8138.2010.01052.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  7 in total

1.  A topical heparinoid-containing product improves epidermal permeability barrier homeostasis in mice.

Authors:  Ye Yao; Pan Guo; Xiaoyue Feng; Chunping Shen; Junkai Huang; Jiechen Zhang; Peter M Elias; Lizhi Hu; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2019-07-04       Impact factor: 3.960

2.  Efficacy and Safety of Mucopolysaccharide Polysulfate Cream for Non-Exudative Eczema: A Systematic Review and Meta-Analysis.

Authors:  Ming Li; Yan Li; Lujing Xiang; Linfeng Li
Journal:  Front Med (Lausanne)       Date:  2021-12-24

3.  Emollient satisfaction questionnaire: validation study in children with eczema.

Authors:  Georgia G Rowley; Stephanie J MacNeill; Matthew J Ridd
Journal:  Clin Exp Dermatol       Date:  2022-05-16       Impact factor: 4.481

4.  Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme.

Authors:  James M Mason; Julie Carr; Carolyn Buckley; Steve Hewitt; Phillip Berry; Josh Taylor; Michael J Cork
Journal:  BMC Dermatol       Date:  2013-05-16

5.  Randomized, prospective assessment of moisturizer efficacy for the treatment of radiation dermatitis following radiotherapy after breast-conserving surgery.

Authors:  Kenji Sekiguchi; Mami Ogita; Keiko Akahane; Chiori Haga; Ryoko Ito; Satoru Arai; Yasushi Ishida; Yoichiro Tsukada; Jiro Kawamori
Journal:  Jpn J Clin Oncol       Date:  2015-10-20       Impact factor: 3.019

6.  Efficacy of heparinoid moisturizer as a prophylactic agent for radiation dermatitis following radiotherapy after breast-conserving surgery: a randomized controlled trial.

Authors:  Kenji Sekiguchi; Keiko Akahane; Mami Ogita; Chiori Haga; Ryoko Ito; Satoru Arai; Yasushi Ishida; Yoichiro Tsukada; Jiro Kawamori
Journal:  Jpn J Clin Oncol       Date:  2018-05-01       Impact factor: 3.019

7.  Tranexamic acid blocks the thrombin-mediated delay of epidermal permeability barrier recovery induced by the cedar pollen allergen, Cry j1.

Authors:  S Nakanishi; J Kumamoto; M Denda
Journal:  Sci Rep       Date:  2018-10-23       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.